Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-02-21

Clinical Trial Update: Effectiveness Study of Vilazodone to Treat Depression and to Discover Genetic Markers Associated With Response [Phase 3]

View source ↗

Summary

A completed Phase 3 study evaluating the effectiveness of vilazodone for major depressive disorder and exploring genetic markers associated with treatment respo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vilazodone (vilazodone)

Snippet

Sponsor: Genaissance Pharmaceuticals | Conditions: Depressive Disorder, Major | Phase 3 | Status: COMPLETED